Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its compelling pipeline of novel therapies aimed at treating metabolic and endocrine disorders...

Viking Therapeutics, Inc. (NASDAQ: VKTX), a promising player in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of clinical-stage therapeutics. Headquartered in San Diego, California,..

Viking Therapeutics, Inc. (VKTX) is capturing the attention of investors with its promising pipeline and remarkable potential for growth. The San Diego-based biotechnology company, with a market capitalization of $3.03..